Navigation Links
Cooperation in diabetes research
Date:10/18/2010

The recently signed cooperation agreement between the MPI of Biochemistry and GSK pursues the objective of developing innovative new drugs. The joint research and development work is based on the research findings of Axel Ullrich, Director at the MPI of Biochemistry. He and fellow scientist Mathias Bcker successfully described the role of certain protein molecules - known as kinases - in connection with the development of type II diabetes, a disease in which insulin resistance gives rise to a raised blood sugar level. These kinases make up a group of important signal molecules in the body, which can, under certain circumstances, be involved in the development or manifestation of the disease. In the collaborative project with GSK, the scientists are looking for new substances that can inhibit this kinase activity and control it in a targeted manner.

Axel Ullrich already achieved a milestone in the treatment of diabetes back in 1977, together with fellow scientists at the University of California. At that time, he developed a method of transferring a copy of the human insulin gene into bacteria. This facilitated the industrial manufacture of human insulin for the very first time and has since made it easier for millions of diabetics to live with the disease, as they no longer have to depend on animal insulin, which is not nearly so well tolerated by the human body.

Axel Ullrich's current research is set to contribute to the successful treatment of diabetes a second time. "Developing innovative drugs to treat diabetes gives us the opportunity to directly influence defects in the molecular signal paths, which lie at the root of diabetes. That enables us to fight the actual causes of diabetes," says Ullrich. Peter Gruss, President of the Max Planck Society expressed his delight with the collaboration agreement: "GlaxoSmithKline is one of the world's five major pharmaceutical companies. The collaboration agreement with GSK testifies to the fact that
'/>"/>

Contact: Markus Berninger
0049-892-909-1930
Max-Planck-Gesellschaft
Source:Eurekalert

Page: 1 2

Related biology news :

1. John P. Holdren addresses climate change, stressing need for international cooperation
2. ARS, industry cooperation yields device to detect insects in stored wheat
3. Leading entomologist to give talk at UCR on communication and cooperation in ant societies
4. HFSP President Arima and Secretary General Winnacker awarded for fostering cooperation with China
5. Nanyang Technological University and UK partners heightens cooperation in water industry
6. World-class innovation through international cooperation
7. T cell discovery shows promise for Type 1 diabetes treatment: UBC-CFRI study
8. Garlic oil shows protective effect against heart disease in diabetes
9. National study finds strong link between diabetes and air pollution
10. Biologists discover biochemical link between biological clock and diabetes
11. Women with diabetes having more C-sections and fetal complications: study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... release is available in German . ... their behavioural response to risky situations such as exposure ... Ornithology now found in a long-term study on different ... both metabolic rate and ambient temperature. High metabolic rates ... as in these scenarios birds were more likely to ...
(Date:9/30/2014)... Winners of The Economist,s prestigious Innovation awards 2014 will ... at the JW Marriott Hong Kong on Friday, October 10 th ... experiences and the lessons those hold for others. The awards, which ... past decade, will be presented at a ceremony in ... be the first time the ceremony has come to ...
(Date:9/29/2014)... Between 1970 and 2010 populations of mammals, birds, ... 52 percent, says the 2014 Living Planet Report ... biodiversity loss occurs disproportionately in low-income countriesand correlates ... , In addition to the precipitous decline in ... warning signs about the overall health of the ...
Breaking Biology News(10 mins):Risky metabolism 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7Half of global wildlife lost, says new WWF report 2
... Data publishers should have the option of submitting ... discussion paper commissioned by the Global Biodiversity Information Facility ... of recommendations made by Mark Costello and co-authors in ... advancing biodiversity data publication , freely available for ...
... 24, 2012 Millions of people with "wet" macular degeneration ... But now scientists at The Scripps Research Institute (TSRI) have ... more harm than good. In the new study, ... VEGF, which has been implicated in stimulating abnormal blood vessel ...
... high resolution draft of the barley genome. The research, published ... new and better barley varieties that are vital for the ... research was led by Professor Robbie Waugh of Scotland,s James ... Centre, Norwich. Barley is the second most important crop ...
Cached Biology News:Peer review option proposed for biodiversity data 2Study suggests caution and further studies on drugs used to treat macular degeneration 2Study suggests caution and further studies on drugs used to treat macular degeneration 3Barley genome could hold key to better beer 2
(Date:10/1/2014)... 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or ... sale of high pressure-based sample preparation systems to the ... invited to present at the 2 nd  Global ... Poland.  The Conference will take place at the Warsaw ... T. Schumacher , President and CEO of PBI, will ...
(Date:10/1/2014)... participants committed to not only creating unique business card ... tweaking and testing virtual models and 3D test prints ... “I enjoyed being involved as a judge,” stated a ... a commendable range exploring the technical capabilities of the ... the creativity of the contestants.” , Array Architects is ...
(Date:10/1/2014)... Slone Partners , a national ... and Laboratory Testing industries, reported a 120% increase in ... level and above from July 2013 to July 2014. ... of rapid breakthroughs in diagnostics, reimbursement has failed to ... been forced to fold, consolidate, or carry on without ...
(Date:9/30/2014)... German . , ... in a semiconductor layer. Quantum dots are small structures that ... a short laser pulse is fired at the photonic crystal, ... a change in the electromagnetic field around it. This change ... by the dot. As soon as the refractive index recovers ...
Breaking Biology Technology:Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 2Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 3Pressure BioSciences, Inc. Invited to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland 4Array Architects Challenges Staff to Create with 3D Printer 2Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation 2Ultrafast remote switching of light emission 2
... (Nasdaq: SPEX ), an innovator in biotechnology ... providers of technical and regulatory consulting services to food, ... President, Dr. Robert Lodder, will be presenting at the ... held in New York next week. Dr. ...
... announced today they have engaged in a pilot with ... Chemotherapy for Cancer patients. Medical and GYN Oncologists and ... (Nashville, TN) using the MiCK assay for apoptosis in ... the best chemotherapy pathway in treating cancer patients. The ...
... BELL, Pa., Feb. 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... of therapeutic and preventive vaccines against cancers and infectious diseases, ... will present a corporate overview on Inovio at the 13th ... York February 14-15, 2011. A live and archived ...
Cached Biology Technology:Spherix to Present at the 13th Annual BIO CEO & Investor Conference 2Spherix to Present at the 13th Annual BIO CEO & Investor Conference 3DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients 2Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference 2Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference 3
Request Info...
... KLH-conjugated, synthetic peptide corresponding ... of human BRAF-HDAC complex protein/Lysine-specific ... Quality Assurance Routinely evaluated ... 2 years at -20°C ...
...
...
Biology Products: